NCT00003951 2012-05-16
DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
Daiichi Sankyo
Phase 2 Completed
Clinical Trials
13 trialsNCT00004045 2012-05-16
Chemotherapy in Treating Patients With Prostate Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004046 2012-05-16
Chemotherapy in Treating Women With Metastatic Breast Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004047 2012-05-16
Chemotherapy in Treating Patients Who Have Hematologic Cancer
Daiichi Sankyo
Phase 1 Completed
NCT00004060 2012-05-16
Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004108 2012-05-16
DX-8951f in Treating Patients With Liver Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004212 2012-05-16
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
Daiichi Sankyo
Phase 1 Completed
NCT00004866 2012-05-16
DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
Daiichi Sankyo
Phase 2 Completed
NCT00005938 2012-05-16
DX-8951f in Treating Patients With Biliary Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00017212 2012-05-16
DX-8951f in Treating Patients With Metastatic Stomach Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00023972 2012-05-16
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Daiichi Sankyo
Phase 3 Completed
NCT00055939 2012-05-16
Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
Daiichi Sankyo
Phase 2 Completed
NCT00055952 2012-05-16
Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
Daiichi Sankyo
Phase 2 Completed